Palvella Therapeutics, Inc. (PVLA) Net income 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$41.7MFY2025 · since FY2016: -$22.8M → -$41.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.7M | -139.3% |
| FY2024 | -$17.4M | -193.3% |
| FY2023 | $18.7M | +156.2% |
| FY2022 | -$33.3M | +27.2% |
| FY2021 | -$45.7M | -22.9% |
| FY2020 | -$37.2M | -46.2% |
| FY2019 | -$25.5M | +4.8% |
| FY2018 | -$26.8M | -51.6% |
| FY2017 | -$17.6M | +22.6% |
| FY2016 | -$22.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice